Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 17 January 2003:
Vol. 299. no. 5605, p. 320
DOI: 10.1126/science.299.5605.320
Prev | Table of Contents | Next

News of the Week

GENE THERAPY:
Second Child in French Trial Is Found to Have Leukemia

Eliot Marshall

For the second time in 4 months, a child has developed a leukemia-like disease after receiving gene therapy at the Necker Hospital for Sick Children in Paris. Concerned about the safety of such trials, the panel that monitors U.S. research in the field scheduled a public meeting this week to review the clinical data and weigh its next steps.

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
The Cellular Amount of the Common {gamma}-Chain Influences Spontaneous or Induced Cell Proliferation.
S. Amorosi, I. Russo, G. Amodio, C. Garbi, L. Vitiello, L. Palamaro, M. Adriani, I. Vigliano, and C. Pignata (2009)
J. Immunol. 182, 3304-3309
   Abstract »    Full Text »    PDF »
Advances in tumour immunotherapy.
J. King, J. Waxman, and H. Stauss (2008)
QJM 101, 675-683
   Abstract »    Full Text »    PDF »
Functional Chimeras of Human Immunodeficiency Virus Type 1 gp120 and Influenza A Virus (H3) Hemagglutinin.
K. M. Copeland, A. J. Elliot, and R. S. Daniels (2005)
J. Virol. 79, 6459-6471
   Abstract »    Full Text »    PDF »
Targeting cerebral arteries for gene therapy.
Y. Watanabe and D. D. Heistad (2005)
Exp Physiol 90, 327-331
   Abstract »    Full Text »    PDF »
L1 retrotransposon-mediated stable gene silencing.
N. Yang, L. Zhang, and H. H. Kazazian Jr (2005)
Nucleic Acids Res. 33, e57
   Abstract »    Full Text »    PDF »
Defects in T-cell-mediated immunity to influenza virus in murine Wiskott-Aldrich syndrome are corrected by oncoretroviral vector-mediated gene transfer into repopulating hematopoietic cells.
T. S. Strom, S. J. Turner, S. Andreansky, H. Liu, P. C. Doherty, D. K. Srivastava, J. M. Cunningham, and A. W. Nienhuis (2003)
Blood 102, 3108-3116
   Abstract »    Full Text »    PDF »
Protection at the cutting edge: the case for central review of human gene transfer research.
J. Kimmelman (2003)
Can. Med. Assoc. J. 169, 781-782
   Full Text »
A gene-deleted adenoviral vector results in phenotypic correction of canine hemophilia B without liver toxicity or thrombocytopenia.
A. Ehrhardt, H. Xu, A. M. Dillow, D. A. Bellinger, T. C. Nichols, and M. A. Kay (2003)
Blood 102, 2403-2411
   Abstract »    Full Text »    PDF »
Performance- and safety-enhanced lentiviral vectors containing the human interferon-{beta} scaffold attachment region and the chicken {beta}-globin insulator.
A. Ramezani, T. S. Hawley, and R. G. Hawley (2003)
Blood 101, 4717-4724
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)